L-arginine reduces heart rate and improves hemodynamics in severe congestive heart failure

47Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Background: Stimulated endothelium-derived relaxing factor-mediated vasodilation and conduit artery distensibility are impaired in congestive heart failure (CHF). L-arginine could have a potentially beneficial role in CHF, acting through the nitric oxide (NO)-L-arginine pathway or by growth hormone increment. Hypothesis: This study was undertaken to investigate the effects of L-arginine on heart rate, hemodynamics, and left ventricular (LV) function in CHF. Methods: In seven patients (aged 39 ± 8 years) with CHF, we obtained the following parameters using echocardiography and an LV Millar Mikro-Tip catheter simultaneously under four conditions: basal, during NO inhalation (40 ppm), in basal condition before L-arginine infusion, and after L-arginine intravenous infusion (mean dose 30.4 ± 1.9 g). Results: Nitric oxide inhalation increased pulmonary capillary wedge pressure from 25 ± 9 to 31 ± 7 mmHg (p < 0.05), but did not change echocardiographic variables or LV contractility by elastance determination. L-arginine decreased heart rate (from 88 ± 15 to 80 ± 16 beats/min, p<0.005), mean systemic arterial pressure (from 84 ± 17 to 70 ± 18 mmHg, p < 0.007), and systemic vascular resistance (from 24 ± 8 to 15 ± 6 Wood units, p < 0.003). L-arginine increased right atrial pressure (from 7 ± 2 to 10 ± 3 mmHg, p <0.04), cardiac output (from 3.4 ± 0.7 to 4.1 ± 0.8 l/min, p < 0.009), and stroke volume (from 40 ± 9 to 54 ± 14 ml, p < 0.008). The ratios of pulmonary vascular resistance to systemic vascular resistance at baseline and during NO inhalation were 0.09 and 0.075, respectively, and with L-arginine this increased from 0.09 to 0.12. Conclusion: L-arginine exerted no effect on contractility; however, by acting on systemic vascular resistance it improved cardiac performance. L-arginine showed a negative chronotropic effect. The possible beneficial effect of L-arginine on reversing endothelial dysfunction in CHF without changing LV contractility should be the subject of further investigations.

Cite

CITATION STYLE

APA

Bocchi, E. A., De Moraes, A. V., Esteves-Filho, A., Bacal, F., Auler, J. O., Carmona, M. J., … Ramires, A. F. (2000). L-arginine reduces heart rate and improves hemodynamics in severe congestive heart failure. Clinical Cardiology, 23(3), 205–210. https://doi.org/10.1002/clc.4960230314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free